California’s CalRx insulin pens will launch Jan. 1 at $11 each, or $55 for a five-pack The state has invested $100 million to lower insulin costs The effort could save patients $2,000 to $4,000 a year ...

Gov. Gavin Newsom speaks during a news conference announcing $11 insulin and prescription drugs with the CalRx program inside a Cedars-Sinai pharmacy in Los Angeles on Thursday. The effort is part of ...

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a ...

Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies ISTANBUL, Oct ...

The global insulin delivery device market is expected to grow at a CAGR of ~8% during the forecast period. The rising prevalence of diabetes globally, increasing adoption of self-administered insulin ...

Luna is the world's smallest iCGM-compatible insulin patch pump with a first-of-its-kind fully closed-loop algorithm designed to make automated insulin delivery easier, lower cost, and accessible to ...

[Image courtesy of Trividia Health] Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK. The new five-bevel pen needle provides healthcare ...

An international expert panel has recently released a comprehensive set of recommendations for optimal insulin injection techniques and equipment. The group, called the Forum for Injection Technique ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics. By Katie Thomas Maricruz Salgado was bringing her ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The diabetes device company said ...

Embecta expects between $25 million and $30 million in pre-tax, cash charges for planned workforce reductions and other associated costs. Embecta expects between $35 million and $45 million in pre-tax ...